• 22 November, 2024
Foreign Affairs, Geopolitics & National Security
MENU

effectiveness

Bharat Biotech’s Covaxin shows 77.8 pc efficacy in Phase III trials, say sources

By Shalini Bhardwaj New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its…

Novavax’s vaccine, also produced by SII, found 90 pc effective against COVID-19 variants

By Sahil Pandey New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine provides 100 per cent protection against moderate and severe symptoms…